Ibrolipim increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol. References: Nishimura M, Imai T, Morioka Y, Kuribayashi S, Kamataki T, Naito S. Effects of NO-1886 (Ibrolipim), a lipoprotein lipase-promoting agent, on gene induction of cytochrome P450s, carboxylesterases, and sulfotransferases in primary cultures of human hepatocytes. Drug Metab Pharmacokinet. 2004 Dec;19(6):422-9. PubMed PMID: 15681896.

纯度：≥98%

CAS：133208-93-2